| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3848673 | American Journal of Kidney Diseases | 2012 | 9 Pages |
Abstract
The FGF-23 pathway may be activated in living kidney donors who show early biochemical changes compatible with chronic kidney disease-mineral and bone disorder. Whether these changes influence bone mineral density and fracture rates warrants consideration.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ann PhD, Anthony B. MD, Neil FRACP, Colin FRCP(Glas), John MD, David MD, Sarbjit Vanita MD, Scott MD, Gregory MD, Norman MD, G.V. Ramesh MD, Darin MD, Amit X. MD, PhD,